BCL2L1 and nasopharyngeal carcinoma: Over-expression of BCL-2 and related family proteins (BCL-xL and MCL-1) confers anti-apoptotic response and contributes to the development of resistance to chemotherapy and radiation treatment for nasopharyngeal carcinoma (NPC) [34].